{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T02:15:40Z","timestamp":1788401740412,"version":"build-2803163510"},"reference-count":41,"publisher":"American Chemical Society (ACS)","issue":"3","license":[{"start":{"date-parts":[[2020,2,17]],"date-time":"2020-02-17T00:00:00Z","timestamp":1581897600000},"content-version":"vor","delay-in-days":14,"URL":"https:\/\/pubs.acs.org\/page\/policy\/authorchoice_ccbyncnd_termsofuse.html"}],"funder":[{"DOI":"10.13039\/na","name":"Djavad Mowafaghian Centre for Brain Health","doi-asserted-by":"publisher","award":["NA"],"award-info":[{"award-number":["NA"]}],"id":[{"id":"10.13039\/na","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,3,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The interaction of dopaminergic and cholinergic neurotransmission in, e.g., Parkinson\u2019s disease has been well established. Here, D2 receptor antagonists were used to assess changes in [18F]-FEOBV binding to the vesicular acetylcholine transporter (VAChT) in rodents using positron emission tomography (PET). After pretreatment with either 10 mg\/kg haloperidol, 1 mg\/kg raclopride, or vehicle, 90 min dynamic PET scans were performed with arterial blood sampling. The net influx rate (Ki) was obtained from Patlak graphical analysis, using a metabolite-corrected plasma input function and dynamic PET data. [18F]-FEOBV concentration in whole-blood or plasma and the metabolite-corrected plasma input function were not significantly changed by the pretreatments (adjusted p &amp;gt; 0.07, Cohen\u2019s d 0.28\u20131.89) while the area-under-the-curve (AUC) of the parent fraction of [18F]-FEOBV was significantly higher after haloperidol treatment (adjusted p = 0.022, Cohen\u2019s d = 2.51) than in controls. Compared to controls, the AUC of [18F]-FEOBV, normalized for injected dose and body weight, was nonsignificantly increased in the striatum after haloperidol (adjusted p = 0.4, Cohen\u2019s d = 1.77) and raclopride (adjusted p = 0.052, Cohen\u2019s d = 1.49) treatment, respectively. No changes in the AUC of [18F]-FEOBV were found in the cerebellum (Cohen\u2019s d 0.63\u20130.74). Raclopride treatment nonsignificantly increased Ki in the striatum 1.3-fold compared to control rats (adjusted p = 0.1, Cohen\u2019s d = 1.1) while it reduced Ki in the cerebellum by 28% (adjusted p = 0.0004, Cohen\u2019s d = 2.2) compared to control rats. Pretreatment with haloperidol led to a nonsignificant reduction in Ki in the striatum (10%, adjusted p = 1, Cohen\u2019s d = 0.44) and a 40\u201350% lower Ki than controls in all other brain regions (adjusted p &amp;lt; 0.0005, Cohen\u2019s d = 3.3\u20134.7). The changes in Ki induced by the selective D2 receptor antagonist raclopride can in part be quantified using [18F]-FEOBV PET imaging. Haloperidol, a nonselective D2\/\u03c3 receptor antagonist, either paradoxically decreased cholinergic activity or blocked off-target [18F]-FEOBV binding to \u03c3 receptors. Hence, further studies evaluating the binding of [18F]-FEOBV to \u03c3 receptors using selective \u03c3 receptor ligands are necessary.<\/jats:p>","DOI":"10.1021\/acs.molpharmaceut.9b01129","type":"journal-article","created":{"date-parts":[[2020,2,3]],"date-time":"2020-02-03T14:40:55Z","timestamp":1580740855000},"page":"865-872","source":"Crossref","is-referenced-by-count":3,"title":["Effect of Dopamine D2 Receptor Antagonists\non [18F]-FEOBV Binding"],"prefix":"10.1021","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7587-8318","authenticated-orcid":true,"given":"Anna","family":"Schildt","sequence":"first","affiliation":[{"name":"University of Groningen, University Medical Center Groningen , , , ,","place":["Groningen, The Netherlands, 9700RB"]},{"name":"University of British Columbia , , 143-2211 Wesbrook Mall , , ,","place":["Vancouver, BC, Canada, V6T 2B5"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik F.J.","family":"de Vries","sequence":"additional","affiliation":[{"name":"University of Groningen, University Medical Center Groningen , , , ,","place":["Groningen, The Netherlands, 9700RB"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoon T.M.","family":"Willemsen","sequence":"additional","affiliation":[{"name":"University of Groningen, University Medical Center Groningen , , , ,","place":["Groningen, The Netherlands, 9700RB"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno Lima","family":"Giacobbo","sequence":"additional","affiliation":[{"name":"University of Groningen, University Medical Center Groningen , , , ,","place":["Groningen, The Netherlands, 9700RB"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodrigo","family":"Moraga-Amaro","sequence":"additional","affiliation":[{"name":"University of Groningen, University Medical Center Groningen , , , ,","place":["Groningen, The Netherlands, 9700RB"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ju\u0308rgen W.A.","family":"Sijbesma","sequence":"additional","affiliation":[{"name":"University of Groningen, University Medical Center Groningen , , , ,","place":["Groningen, The Netherlands, 9700RB"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aren","family":"van Waarde","sequence":"additional","affiliation":[{"name":"University of Groningen, University Medical Center Groningen , , , ,","place":["Groningen, The Netherlands, 9700RB"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vesna","family":"Sossi","sequence":"additional","affiliation":[{"name":"University of British Columbia , , 143-2211 Wesbrook Mall , , ,","place":["Vancouver, BC, Canada, V6T 2B5"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rudi A.J.O.","family":"Dierckx","sequence":"additional","affiliation":[{"name":"University of Groningen, University Medical Center Groningen , , , ,","place":["Groningen, The Netherlands, 9700RB"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janine","family":"Doorduin","sequence":"additional","affiliation":[{"name":"University of Groningen, University Medical Center Groningen , , , ,","place":["Groningen, The Netherlands, 9700RB"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"316","published-online":{"date-parts":[[2020,2,3]]},"reference":[{"issue":"4","key":"2026090221481334100_cit1","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1002\/ana.20834","article-title":"The Parkinson\u2019s\nComplex: Parkinsonism Is Just the Tip of the Iceberg","volume":"59","author":"Langston","year":"2006","journal-title":"Ann. Neurol."},{"issue":"2","key":"2026090221481334100_cit2","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","article-title":"Staging of Brain Pathology Related\nto Sporadic Parkinson\u2019s Disease","volume":"24","author":"Braak","year":"2003","journal-title":"Neurobiol.\nAging"},{"issue":"7","key":"2026090221481334100_cit3","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1038\/nrn.2017.62","article-title":"Non-Motor Features\nof Parkinson Disease","volume":"18","author":"Schapira","year":"2017","journal-title":"Nat. Rev. Neurosci."},{"issue":"9","key":"2026090221481334100_cit4","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1007\/s11910-013-0377-9","article-title":"Cholinergic Dysfunction in Parkinson\u2019s Disease","volume":"13","author":"Mu\u0308ller","year":"2013","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"2026090221481334100_cit5","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1016\/S0140-6736(14)61393-3","article-title":"Parkinson\u2019s Disease","volume":"386","author":"Kalia","year":"2015","journal-title":"Lancet"},{"issue":"35","key":"2026090221481334100_cit6","doi-asserted-by":"publisher","first-page":"11163","DOI":"10.1021\/bi049562b","article-title":"Acetylcholine Binding\nSite in the\nVesicular Acetylcholine Transporter","volume":"43","author":"Ojeda","year":"2004","journal-title":"Biochemistry"},{"issue":"4","key":"2026090221481334100_cit7","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1111\/j.1471-4159.2010.06990.x","article-title":"Search for the Acetylcholine and\nVesamicol Binding Sites in Vesicular Acetylcholine Transporter: The\nRegion around the Lumenal End of the Transport Channel","volume":"115","author":"Khare","year":"2010","journal-title":"J. Neurochem."},{"issue":"4","key":"2026090221481334100_cit8","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1111\/j.1471-4159.1986.tb00640.x","article-title":"Acetylcholine Transport\nand Drug Inhibition Kinetics\nin Torpedo Synaptic Vesicles","volume":"46","author":"Bahr","year":"1986","journal-title":"J. Neurochem."},{"issue":"4","key":"2026090221481334100_cit9","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1002\/(SICI)1096-9861(19970224)378:4&lt;454::AID-CNE2&gt;3.0.CO;2-1","article-title":"Vesicular Acetylcholine\nTransporter (VAChT) Protein: A Novel and Unique Marker for Cholinergic\nNeurons in the Central and Peripheral Nervous Systems","volume":"378","author":"Arvidsson","year":"1997","journal-title":"J. Comp. Neurol."},{"issue":"1","key":"2026090221481334100_cit10","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/S0891-0618(97)00021-5","article-title":"Localization of Two\nCholinergic Markers, Choline Acetyltransferase and Vesicular Acetylcholine\nTransporter in the Central Nervous System of the Rat: In Situ Hybridization\nHistochemistry and Immunohistochemistry","volume":"13","author":"Ichikawa","year":"1997","journal-title":"J.\nChem. Neuroanat."},{"issue":"4","key":"2026090221481334100_cit11","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1002\/ana.25430","article-title":"Cholinergic\nSystem Changes of Falls and Freezing of Gait in Parkinson\u2019s\nDisease","volume":"85","author":"Bohnen","year":"2019","journal-title":"Ann. Neurol."},{"key":"2026090221481334100_cit12","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.sleep.2018.12.020","article-title":"Brain Cholinergic\nAlterations in Idiopathic REM Sleep Behaviour Disorder: A PET Imaging\nStudy with 18F-FEOBV","volume":"58","author":"Bedard","year":"2019","journal-title":"Sleep Med."},{"issue":"1","key":"2026090221481334100_cit13","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/S0361-9230(96)00351-6","article-title":"Regulation\nof Dopamine D1 and D2 Receptors on Striatal Acetylcholine Release\nin Rats","volume":"43","author":"Ikarashi","year":"1997","journal-title":"Brain Res. Bull."},{"issue":"2\u20133","key":"2026090221481334100_cit14","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/S0014-2999(96)00761-3","article-title":"Spontaneous\nRelease of Acetylcholine\nin Striatum Is Preferentially Regulated by Inhibitory Dopamine D2\nReceptors","volume":"317","author":"DeBoer","year":"1996","journal-title":"Eur. J. Pharmacol."},{"issue":"2","key":"2026090221481334100_cit15","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/S0022-3565(25)12934-0","article-title":"Physiological Release of Striatal Acetylcholine in\nVivo: Modulation by D1 and D2 Dopamine Receptor Subtypes","volume":"277","author":"DeBoer","year":"1996","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"12","key":"2026090221481334100_cit16","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1097\/00001756-199309150-00006","article-title":"Striatal D2\/Acetylcholine\nInteractions: PET Studies of the Vesamicol Receptor","volume":"4","author":"Ingvar","year":"1993","journal-title":"NeuroReport"},{"issue":"7","key":"2026090221481334100_cit17","first-page":"1192","article-title":"Age-Related\nDiminution of Dopamine\nAntagonist Stimulated Vesamicol Receptor Binding","volume":"37","author":"Efange","year":"1996","journal-title":"J. Nucl. Med."},{"issue":"2","key":"2026090221481334100_cit18","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.nucmedbio.2015.11.003","article-title":"Kinetics Modeling and Occupancy Studies of a Novel\nC-11 PET Tracer for VAChT in Nonhuman Primates","volume":"43","author":"Jin","year":"2016","journal-title":"Nucl. Med. Biol."},{"issue":"3","key":"2026090221481334100_cit19","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1002\/(SICI)1098-2396(199811)30:3&lt;263::AID-SYN4&gt;3.0.CO;2-9","article-title":"[18F]Fluoroethoxy-Benzovesamicol,\na PET Radiotracer for the Vesicular Acetylcholine Transporter and\nCholinergic Synapses","volume":"30","author":"Mulholland","year":"1998","journal-title":"Synapse"},{"issue":"5","key":"2026090221481334100_cit20","first-page":"815","article-title":"Reproducibility\nof 11C-Raclopride Binding in the Rat\nBrain Measured with the MicroPET R4: Effects of Scatter Correction\nand Tracer Specific Activity","volume":"44","author":"Alexoff","year":"2003","journal-title":"J. Nucl. Med."},{"issue":"7","key":"2026090221481334100_cit21","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1002\/jlcr.2580330704","article-title":"Synthesis\nof [18F]Fluoroethoxy-Benzovesamicol, a Radiotracer for\nCholinergic Neurons","volume":"33","author":"Mulholland","year":"1993","journal-title":"J. Labelled Compd. Radiopharm."},{"issue":"3","key":"2026090221481334100_cit22","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0122363","article-title":"A Standardized Method for the Construction\nof Tracer Specific PET and SPECT Rat Brain Templates: Validation and\nImplementation of a Toolbox","volume":"10","author":"Va\u0301llez Garcia","year":"2015","journal-title":"PLoS One"},{"issue":"1","key":"2026090221481334100_cit23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/jcbfm.1983.1","article-title":"Graphical\nEvaluation of Blood-to-Brain\nTransfer Constants from Multiple-Time Uptake Data","volume":"3","author":"Patlak","year":"1983","journal-title":"J. Cereb. Blood Flow Metab."},{"issue":"8","key":"2026090221481334100_cit24","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1016\/j.ijnurstu.2012.01.015","article-title":"Effect Size\nEstimation: Methods and\nExamples","volume":"49","author":"Berben","year":"2012","journal-title":"Int. J. Nurs. Stud."},{"issue":"2","key":"2026090221481334100_cit25","doi-asserted-by":"publisher","first-page":"597","DOI":"10.22237\/jmasm\/1257035100","article-title":"New Effect\nSize Rules of Thumb","volume":"8","author":"Sawilowsky","year":"2009","journal-title":"J. Mod. Appl. Stat. Methods"},{"issue":"16","key":"2026090221481334100_cit26","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1016\/0024-3205(96)00103-8","article-title":"The Vesamicol Receptor\nLigand (+)-Meta-[125I]Iodobenzyltrozamicol {(+)-[125I]-MIBT} Reveals\nBlunting of the Striatal Cholinergic Response to Dopamine D2 Receptor\nBlockade in the 6-Hydroxydopamine (6-OHDA)-Lesioned Rat: Possible\nImplications for Parkinson\u2019","volume":"58","author":"Efange","year":"1996","journal-title":"Life Sci."},{"issue":"3","key":"2026090221481334100_cit27","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1111\/j.1755-5949.2008.00047.x","article-title":"A Review of the Discovery, Pharmacological Characterization,\nand Behavioral Effects of the Dopamine D2-like Receptor Antagonist\nEticlopride","volume":"14","author":"Martelle","year":"2008","journal-title":"CNS Neurosci. Ther."},{"issue":"13","key":"2026090221481334100_cit28","doi-asserted-by":"publisher","first-page":"2251","DOI":"10.1016\/0006-2952(85)90778-6","article-title":"Specific in Vitro and\nin Vivo Binding of 3H-Raclopride a Potent Substituted Benzamide Drug\nwith High Affinity for Dopamine D-2 Receptors in the Rat Brain","volume":"34","author":"Ko\u0308hler","year":"1985","journal-title":"Biochem. Pharmacol."},{"issue":"1","key":"2026090221481334100_cit29","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1002\/syn.890120106","article-title":"Quantitation of Carbon-11-Labeled\nRaclopride in Rat\nStriatum Using Positron Emission Tomography","volume":"12","author":"Hume","year":"1992","journal-title":"Synapse"},{"issue":"2","key":"2026090221481334100_cit30","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S0022-3565(25)30420-9","article-title":"In Vivo Actions of\nClozapine and Haloperidol on the Turnover Rate of Acetylcholine in\nRat Striatum","volume":"196","author":"Racagni","year":"1976","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"3","key":"2026090221481334100_cit31","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1021\/acschemneuro.7b00018","article-title":"Classics in Chemical Neuroscience:\nHaloperidol","volume":"8","author":"Tyler","year":"2017","journal-title":"ACS Chem. Neurosci."},{"issue":"4","key":"2026090221481334100_cit32","doi-asserted-by":"publisher","first-page":"327","DOI":"10.3109\/10799893.2015.1015737","article-title":"Sigma Receptors\n[ \u03c3 Rs]: Biology in Normal and\nDiseased States","volume":"36","author":"Rousseaux","year":"2016","journal-title":"J. Recept. Signal Transduction\nRes."},{"key":"2026090221481334100_cit33","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.ejmech.2015.05.033","article-title":"New Systematically\nModified Vesamicol Analogs and Their Affinity and Selectivity for\nthe Vesicular Acetylcholine Transporter - A Critical Examination of\nthe Lead Structure","volume":"100","author":"Barthel","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"2026090221481334100_cit34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2018\/4535476","article-title":"In Vivo and in Vitro\nCharacteristics of Radiolabeled Vesamicol Analogs\nas the Vesicular Acetylcholine Transporter Imaging Agents","volume":"2018","author":"Ogawa","year":"2018","journal-title":"Contrast Media Mol. Imaging"},{"issue":"21","key":"2026090221481334100_cit35","doi-asserted-by":"publisher","first-page":"7659","DOI":"10.1016\/j.bmc.2010.08.028","article-title":"3D QSAR Study, Synthesis, and in\nVitro Evaluation of (+)-5-FBVM as Potential PET Radioligand for the\nVesicular Acetylcholine Transporter (VAChT)","volume":"18","author":"Kovac","year":"2010","journal-title":"Bioorg. Med. Chem."},{"issue":"3","key":"2026090221481334100_cit36","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1002\/syn.890170307","article-title":"Sigma-1\nand Sigma-2 Sites in Rat\nBrain: Comparison of Regional, Ontogenetic, and Subcellular Patterns","volume":"17","author":"McCann","year":"1994","journal-title":"Synapse"},{"issue":"2","key":"2026090221481334100_cit37","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/S0306-4522(96)00221-7","article-title":"[3H]1,3-Di(2-Tolyl)Guanidine and [3H](+)Pentazocine\nBinding Sites in the Rat Brain: Autoradiographic Visualization of\nthe Putative Sigma1 and Sigma2 Receptor Subtypes","volume":"76","author":"Bouchard","year":"1997","journal-title":"Neuroscience"},{"issue":"4","key":"2026090221481334100_cit38","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1007\/s11307-015-0917-6","article-title":"Sigma-1 Agonist Binding in the Aging Rat\nBrain: A MicroPET Study with [11C]SA4503","volume":"18","author":"Ramakrishnan","year":"2016","journal-title":"Mol.\nImaging Biol."},{"issue":"S1","key":"2026090221481334100_cit39","doi-asserted-by":"publisher","first-page":"S238","DOI":"10.1002\/jlcr.3725","article-title":"Pd Catalyzed Cross-coupling of [11C]MeLi\nand Its Application in the Synthesis and Evaluation of a Potential\nPET Tracer for the Vesicular Acetylcholine Transporter (VAChT)","volume":"62","author":"Helbert","year":"2019","journal-title":"J. Labelled Compd. Radiopharm."},{"issue":"4","key":"2026090221481334100_cit40","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1093\/bja\/aes448","article-title":"Presynaptic\nInhibition of the Release\nof Multiple Major Central Nervous System Neurotransmitter Types by\nthe Inhaled Anaesthetic Isoflurane","volume":"110","author":"Westphalen","year":"2013","journal-title":"Br. J. Anaesth."},{"issue":"10","key":"2026090221481334100_cit41","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1111\/j.1399-6576.1997.tb04654.x","article-title":"Effects of\nIsoflurane on in Vivo\nRelease of Acetylcholine in the Rat Cerebral Cortex and Striatum","volume":"41","author":"Shichino","year":"1997","journal-title":"Acta Anaesthesiol. Scand."}],"container-title":["Molecular\nPharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/pubs.acs.org\/doi\/pdf\/10.1021\/acs.molpharmaceut.9b01129","content-type":"application\/pdf","content-version":"vor","intended-application":"unspecified"},{"URL":"https:\/\/pubs.acs.org\/mpohbp\/article-pdf\/17\/3\/865\/67091408\/acs.molpharmaceut.9b01129.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/pubs.acs.org\/mpohbp\/article-pdf\/17\/3\/865\/67091408\/acs.molpharmaceut.9b01129.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T01:49:59Z","timestamp":1788400199000},"score":1,"resource":{"primary":{"URL":"https:\/\/pubs.acs.org\/mpohbp\/article\/17\/3\/865\/507365\/Effect-of-Dopamine-D2-Receptor-Antagonists-on-18F"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,3]]},"references-count":41,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2020,2,3]]},"published-print":{"date-parts":[[2020,3,2]]}},"URL":"https:\/\/doi.org\/10.1021\/acs.molpharmaceut.9b01129","relation":{},"ISSN":["1543-8384","1543-8392"],"issn-type":[{"value":"1543-8384","type":"print"},{"value":"1543-8392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2,3]]}}}